Mostrar Notícias:

SEPRPrincipaisÚltima HoraBovespa - Brasil

 Ver notícias de outros activos

Pesquisa de notícias relativas à acção Sepracor Inc. (ordenadas pela data):

Paris Ledger

Global Asthma Medication Market Analysis 2018-2025 : Dulera, Merck, Roche, Sepracor, Sanofi Paris Ledger The competitive analysis contains identifying the key common trends and major players in the market such as [Dulera, QVAR, Glaxosmithkline plc, MAP Pharmaceuticals,Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, ... e mais »

Medgadget (blog)

Obstructive Lung Disease Market 2018 Epidemiology, Drugs Uptake, Upcoming Therapies and Highly Analysed ... Medgadget (blog) (U.S.), Genentech Inc. (U.S.), Sepracor, Inc. (U.S.), Skyepharma plc (U.S.). Global Obstructive Lung Disease Market: Segmentation. The obstructive lung disease is segmented on the basis of disease type, product type, drug class, route of administration ... e mais »

Photocure ASA: Daniel Schneider appointed Chief Executive Officer GlobeNewswire (press release) Mr Schneider has also held executive management positions in other pharmaceutical and biotech companies, including BTG International, Somaxon Pharmaceuticals and Sepracor. ... The US headquarters for Photocure Inc., are in Princeton, New Jersey. e mais »

Three PM News (blog)

Global Desloratadine Market 2018 Major Players ? Hairui Pharmaceutical, Mayne Pharma Inc, Pfizer, Sepracor, Mylan ... Three PM News (blog) Global Desloratadine Market Research Report 2018-2023 published and promoted by GenMarketInsights.com provides in-depth segment analysis of the market being effective in several sectors, thereby providing valuable insights to the rivals.

The Business Investor

Global Asthma Medication Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 ? 2025 The Business Investor Global Asthma Medication market is valued at USD XX million in 2018 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2018 and 2022. Asthma is chronic inflammatory lung disease. Asthma affects the ...

Tactical Business

Asthma Medication-Global Market Outlook 2018-2025 Tactical Business Global Asthma Medication Market : This report studies the global market size of Asthma Medication in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Asthma Medication ... e mais »

managementjournal24.com

Asthma Medication Market to 2025 ?Global Market Size, Development Status, Top Manufacturers, and Forecasts managementjournal24.com Global Asthma Medication market Review Forecast to 2023 ? Analysis by Chemical Type, Technology, Application, End-User, Industry Vertical, and Region' into its vast depository of research reports. In the first section of the report, the market ... e mais »

Desloratadine Market Analysis, Overview, Growth, Demand and Forecast Research Report to 2025 Chronicle India Top Key Players of Desloratadine Market: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin ...

CB Reporter

Worldwide Desloratadine Market Research Report 2018: Progress, Size, Share, Development, Trends And Estimates ... CB Reporter Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ... e mais »

Global Desloratadine Market Research Study including Growth Factors, Types and Application by regions from 2017 to ... Chronicle India Desloratadine Market report offers an inclusive and decision-making overview, including definitions, classifications and its applications. The Desloratadine market is anticipated to reflect a positive growth trend in forthcoming years. The essential ... e mais »

Global Desloratadine Market Growth Trends,Type ,Application , Revenue ,Size ,Demand , Research Approach and ... Trade Market Research Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan ... e mais »

trueindustrynews.com

Global Asthma and COPD Drugs market is expected to reach $50359 million by 2022 trueindustrynews.com ... (U.K), Roche Holding AG (Switzerland), Teva Pharmaceutical Industries (Israel), Vectura Group (U.K), Pfizer (U.S). Other players in the value chain include Mylan, Aerovance Inc. Alkermes Inc. Almirall SA. Genentech Inc. Sepracor, Inc. Skyepharma plc. e mais »

Asthma Medication Market Insights, Forecast to 2025 Market By Manufactures, Product scope and Trends 2018 to 2023 theperfectinvestor.com Global Asthma Medication Market Insights, Forecast to 2025 Market Professional Survey Report 2018?provides strategists, marketers and senior management with the critical information they need to assess the global Asthma Medication Market Insights, ... e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO BSA bureau (press release) In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ... e mais »

GlobeNewswire (press release)

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer GlobeNewswire (press release) Mr. Hastings also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule's transition into a drug discovery and development organization, and in two ...

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary Business Wire (press release) Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ... e mais »

Business Wire (press release)

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ... Business Wire (press release) Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma. e mais »

Business Wire (press release)

Entasis Therapeutics Appoints David C. Hastings to Board of Directors Business Wire (press release) BUSINESS WIRE)--Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the appointment of David C. Hastings to the company's Board of ... e mais »

Business Wire (press release)

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development Business Wire (press release) She then joined Sunovion Pharmaceuticals, Inc. (formerly Sepracor), moving through positions of increasing responsibility into the role of vice president for corporate development and licensing. Sullivan played an instrumental role in the company's ...

greenenergy24.com

Global Loratadine Market 2018 Exclusive Manufacturers- Sandoz, Mylan and Sepracor greenenergy24.com A latest detailed analysis on Global Loratadine Market report studies the new opportunity appraisal of Loratadine market (2018 ? 2023). According to the Loratadine business intelligence analysis, the global Loratadine market is likely to rise to X.X ... e mais »

Talk Investor (press release) (blog)

Global Desloratadine Market research report 2018: Predictable to exceed Market Income, Shares and competitive ... Talk Investor (press release) (blog) Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ... e mais »

Minerva Neurosciences Names Richard Russell President GlobeNewswire (press release) 11, 2017 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced the appointment of Rick Russell ... e mais »

Bellicum Pharmaceuticals Appoints Edmund P. Harrigan, MD to its Board of Directors GlobeNewswire (press release) In addition to his experience at Pfizer, Dr. Harrigan previously served as President & CEO of Karuna Pharmaceuticals, and in senior clinical leadership positions at Neurogen Corp. and Sepracor, Inc. Prior to entering the pharmaceutical industry in 1990 ... e mais »

Business Wire (press release)

Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launch Business Wire (press release) BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of product candidates using its proprietary mucus-penetrating particle (MPP) technology, today announced the ...

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer Business Wire (press release) Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ... e mais »

Sepracor Inc. to Become Sunovion Pharmaceuticals Inc. Business Wire (press release) MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sepracor Inc. (Sepracor) and Dainippon Sumitomo Pharma Co., Ltd. (DSP), an Osaka, Japan-based pharmaceutical company, announced today the intent to change the Sepracor name to Sunovion ... e mais »

The Boston Globe

Japanese executives ponder investing in Mass. The Boston Globe They visited a giant laboratory in Cambridge shared by emerging biotech companies and walked the life sciences mecca that is Kendall Square. They met with government officials who want to lure foreign companies to Massachusetts. They even saw the ...

Sunovion Pharmaceuticals Inc. Announces Company Name Change Business Wire (press release) MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc. (Sunovion), formerly Sepracor Inc. (Sepracor), announced today that it has formally changed its name. The change occurs on approximately the one year anniversary of the ... e mais »

Allergy Treatment Market Pegged to Expand Robustly During 2016-2026 advertisingmarket24.com ... treatment market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc.

TheChronicleHerald.ca

PEI's BioVectra buys former Sepracor plant in Windsor TheChronicleHerald.ca A Charlottetown drug manufacturer has acquired a mothballed Windsor pharmaceutical plant and plans to reopen the facility in early 2016. BioVectra Inc. purchased the former Sepracor Canada (Nova Scotia) Ltd. facility in May. The Sepracor operation ... Charlottetown's BioVectra expanding, setting up in WindsorHants Journal todos os 5 artigos de notícias »